DMRA - Galecto, Inc.
25.42
-0.480 -1.888%
Share volume: 109,046
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$25.90
-0.48
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-29-2024 | 08-12-2024 | 11-01-2024 | 03-19-2025 | 05-08-2025 | 11-06-2025 | 03-19-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 5.741 M | 4.609 M | 3.840 M | 7.102 M | 2.599 M | 3.156 M | 201.696 M | |
| Selling general and admin | 3.278 M | 2.775 M | 2.747 M | 1.699 M | 1.921 M | 1.740 M | 4.068 M | |
| Research and development | 2.463 M | 1.834 M | 1.093 M | 5.403 M | 678.000 K | 1.416 M | 197.628 M | |
| Total expenses | 5.741 M | 5.577 M | 3.840 M | 7.102 M | 2.599 M | 3.156 M | 201.696 M | |
| -2.86% | -31.15% | 84.95% | -63.40% | 21.43% | 6,290.87% | |||
| Operating income | -5.741 M | -5.577 M | -3.840 M | -7.102 M | -2.599 M | -3.156 M | -201.696 M | |
| Ebit | -5.734 M | -5.509 M | -4.022 M | -6.977 M | -2.605 M | -3.175 M | -201.693 M | |
| Pretax income | -5.477 M | -5.296 M | -3.876 M | -6.749 M | -2.531 M | -3.133 M | -200.692 M | |
| -3.30% | -26.81% | 74.12% | -62.50% | 23.79% | 6,305.75% | |||
| Income tax | 0.000 | 42.000 K | 7.000 K | 0.000 | 2.000 K | 0.000 | 44.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.477 M | -5.338 M | -3.883 M | -6.741 M | -2.533 M | -3.133 M | -200.736 M | |
| 2.54% | 27.26% | -73.60% | 62.42% | -23.69% | -6,307.15% |